Molina Healthcare (MOH) Gets a Hold from Truist Financial
In a report released yesterday, David S Macdonald from Truist Financial maintained a Hold rating on Molina Healthcare, with a price target of $145.00.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
According to TipRanks, S Macdonald is a 5-star analyst with an average return of 10.6% and a 58.20% success rate. S Macdonald covers the Healthcare sector, focusing on stocks such as Molina Healthcare, Tenet Healthcare, and PACS Group Inc.
In addition to Truist Financial, Molina Healthcare also received a Hold from J.P. Morgan’s John Stansel in a report issued on February 13. However, on February 10, Barclays maintained a Sell rating on Molina Healthcare (NYSE: MOH).
Based on Molina Healthcare’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $11.38 billion and a GAAP net loss of $160 million. In comparison, last year the company earned a revenue of $10.5 billion and had a net profit of $251 million
Based on the recent corporate insider activity of 65 insiders, corporate insider sentiment is neutral on the stock. Earlier this month, Richard Zoretic, a Director at MOH bought 800.00 shares for a total of $100,128.00.
Read More on MOH:
Disclaimer & DisclosureReport an Issue
- Molina Healthcare price target lowered to $142 from $194 at JPMorgan
- Molina Healthcare’s Margins at Risk as Medicaid Rates Lag Rising Medical Costs
- Molina Healthcare price target lowered to $124 from $167 at Goldman Sachs
- Molina Healthcare price target lowered to $109 from $165 at Deutsche Bank
- Molina Healthcare price target lowered to $133 from $164 at Barclays
